Asnuciclib

N/A

Report date: 2026/01/06 15:22:20
NME

Base Information

Drug NameAsnuciclib
Drug Alias NameCDKI-73LS-007QHRD-107
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsSerine/threonine-protein kinase Aurora-A inhibitorsSerine/threonine-protein kinase Aurora-B inhibitors +[7] 
TargetsCyclin-dependent kinase 9Serine/threonine-protein kinase Aurora-ASerine/threonine-protein kinase Aurora-B +[7] 
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesUniversity Of South AustraliaShandong University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesUniversity Of South AustraliaChangzhou Qianhong Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A